Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Protocols Will Test Effects of RFID on Medical Devices

07.10.2009
Radio frequency identification (RFID) systems are widely used for applications that include inventory management, package tracking, toll collection, passport identification and airport luggage security. More recently, these systems have found their way into medical environments to track patients, equipment assets and staff members.

However, there is currently no published standardized, repeatable methodology by which manufacturers of RFID equipment or medical devices can assess potential issues with electromagnetic interference and evaluate means to mitigate them.

To resolve these concerns, the Georgia Tech Research Institute (GTRI) recently began developing testing protocols for RFID technology in the health care setting. The test protocol development is being overseen by AIM Global, the international trade association representing automatic identification and mobility technology solution providers, and also includes MET Laboratories, a company that provides testing and certification services for medical devices.

“A comprehensive set of test protocols, which are sufficiently precise to permit repeatable results, is required to understand if there is an interaction between various types of RFID systems and active implantable medical devices, electronic medical equipment, in vitro diagnostic equipment and biologics. Only after the protocols are developed will we be able to investigate the cause of any interactions, the result of any interactions, and ways manufacturers might eliminate or mitigate interactions,” said Craig K. Harmon, president and CEO of Q.E.D. Systems and chairman of AIM Global’s RFID Experts Group. This group is overseeing the Health Care Initiative and includes representatives from 40 organizations in the United States, Europe and Asia.

GTRI researchers will test how RFID systems affect the function of implantable and wearable medical devices, such as pacemakers, implantable cardioverter defibrillators, neurostimulators, implantable infusion pumps and cardiac monitors.

“The internal components, firmware and hardware of every company’s devices are different, meaning that each device can respond differently to the same electromagnetic environment. Since there have been various preliminary tests and publications from different organizations indicating that there may or may not be issues with RFID system environments and these devices, it is important to standardize the way to test such devices,” said Ralph Herkert, director of GTRI’s Medical Device Test Center.

Herkert and Gisele Bennett, director of GTRI’s Electro-Optical Systems Laboratory, will evaluate and determine the best method for measuring whether interference takes place as a result of RFID emission in both active and passive RFID technologies covering the spectrum from low-frequency to ultra high-frequency.

The researchers will test whether radio frequency-emitting devices cause any negative effects on the medical devices, and under what conditions these effects might occur. Testing will also determine whether specific medical devices are particularly susceptible to certain radio frequency identification characteristics and if any corrective actions can be taken to mitigate such susceptibility.

Medical device testing is not new for GTRI, which established its Medical Device Test Center more than 14 years ago. The facility was created to enable manufacturers of implantable cardiac pacemakers and defibrillators to work with providers of electronic article surveillance (EAS) systems, used by retailers, libraries and other establishments to prevent theft and track inventory. The center’s original mission was to help manufacturers improve compatibility between implantable medical devices and EAS systems that radiate electromagnetic energy. In 2006, GTRI expanded its operations and facilities to test new types of security and logistical systems (SLS), including RFID.

To test the effects of RFID systems on medical devices, the researchers simulate real-world conditions by placing a medical device in a tank of saline solution that simulates the electrical characteristics of body tissue and fluid. The medical device is then exposed to different RFID technologies. Several tests are performed with the device placed in different orientations to represent how people typically interact with the emissions.

“We think the testing procedure for RFID systems will be similar to the EAS system procedure, but there are a few more challenges with the RFID systems because a person doesn’t always pass through a portal,” noted Bennett, who is also a member of AIM Global’s RFID Experts Group. “Medical devices can be affected by active tags with stronger signals or RFID systems reading passive tag signals.”

The test protocols developed by GTRI will be submitted to the U.S. Food and Drug Administration for concurrence, after which a worldwide certification program will be launched and other testing facilities will be invited to participate.

Funding to develop these test guidelines is currently being provided by GTRI, but the researchers are actively looking for external funding.

“We have more than 35 years of experience at GTRI testing medical device interference and we think that testing the effects of RFID on medical devices is an important area to pursue,” added Bennett.

Research News & Publications Office
Georgia Institute of Technology
75 Fifth Street, N.W., Suite 100
Atlanta, Georgia 30308 USA

Abby Vogel | Newswise Science News
Further information:
http://www.gatech.edu

Further reports about: AIM EAS GTRI GTRI’s Medical Wellness RFID RFID systems implantable medical devices

More articles from Information Technology:

nachricht World first: 'Storing lightning inside thunder'
18.09.2017 | University of Sydney

nachricht New software turns mobile-phone accessory into breathing monitor
14.09.2017 | The Optical Society

All articles from Information Technology >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...

Im Focus: Artificial Enzymes for Hydrogen Conversion

Scientists from the MPI for Chemical Energy Conversion report in the first issue of the new journal JOULE.

Cell Press has just released the first issue of Joule, a new journal dedicated to sustainable energy research. In this issue James Birrell, Olaf Rüdiger,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

New quantum phenomena in graphene superlattices

19.09.2017 | Physics and Astronomy

A simple additive to improve film quality

19.09.2017 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>